Alnylam Pharmaceuticals | ALNY - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amgen USD 2.38B 556M 2026-06
Arrowhead Research USD -194.28M 61.55M 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Incyte USD 585.6M 282.27M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Moderna USD -1.34B 517M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novartis USD 3.16B 747M 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 1.61B 2.42B 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Takeda JPY 113.2B 137.52B 2026-06
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06
Xencor USD -21.73M 107.19M 2026-06